NASDAQ:BTTX

Better Therapeutics (BTTX) Stock Price, News & Analysis

Better Therapeutics logo
$0.0001 0.00 (0.00%)
As of 11/12/2026

About Better Therapeutics Stock (NASDAQ:BTTX)

Advanced

Key Stats

Today's Range
$0.0001
▼
$0.0001
50-Day Range
N/A
52-Week Range
$0.0001
▼
$0.0002
Volume
3,801 shs
Average Volume
9,489 shs
Market Capitalization
$4.06 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Better Therapeutics was a U.S.-based digital health company that developed prescription digital therapeutics for cardiometabolic conditions. Its software-based treatments used principles of cognitive behavioral therapy to help patients make changes to behaviors associated with chronic disease.

The company’s lead product, AspyreRx, was authorized by the U.S. Food and Drug Administration in 2023 as a prescription digital therapeutic for adults with type 2 diabetes. Designed for use alongside standard care, the program aimed to help patients improve blood sugar management through structured behavioral therapy delivered digitally.

Better Therapeutics later announced that it would wind down its operations. Its business centered on the development of digital treatment programs rather than conventional drugs or medical devices.

AI Generated. May Contain Errors.

Receive BTTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Better Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BTTX Stock News Headlines

BTTX Better Therapeutics, Inc. - Seeking Alpha
Worse than socialism
Donald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.tc pixel
Janux Therapeutics Inc (JANX) Receives a Buy from BTIG
See More Headlines

BTTX Stock Analysis - Frequently Asked Questions

Better Therapeutics' stock was trading at $0.0001 at the beginning of 2026. Since then, BTTX stock has increased by 0.0% and is now trading at $0.0001.

Based on aggregate information from My MarketBeat watchlists, some other companies that Better Therapeutics investors own include NIO (NIO), Advanced Micro Devices (AMD), MARA (MARA), Peloton Interactive (PTON), Ginkgo Bioworks (DNA), Ford Motor (F) and Aterian (ATER).

Company Calendar

Today
11/21/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Health services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:BTTX
CIK
1832415
Fax
N/A
Employees
54
Year Founded
2015

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
40,580,000
Free Float
24,233,000
Market Cap
$4.06 thousand
Optionable
No Data
Beta
0.91

Social Links

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (NASDAQ:BTTX) was last updated on 11/12/2026 by MarketBeat.com Staff.
From Our Partners